ESSA Pharma Inc.
EPIX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,003 | -$6,375 | -$8,532 | -$6,355 |
| Dep. & Amort. | $16 | $24 | $23 | -$61 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | -$634 | $1,172 | $2,702 | $2,003 |
| Change in WC | $402 | -$1,492 | -$399 | $290 |
| Other Non-Cash | $18 | -$178 | -$264 | $758 |
| Operating Cash Flow | -$4,200 | -$6,849 | -$6,470 | -$3,366 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$2,056 | -$15,379 | -$12,029 | -$11,467 |
| Inv. Sales/Matur. | $5,900 | $15,225 | $8,100 | $32,491 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $3,844 | -$154 | -$3,929 | $21,024 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $63 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $707 |
| Financing Cash Flow | $0 | $0 | $0 | $60 |
| Forex Effect | $0 | $0 | $0 | $6 |
| Net Chg. in Cash | -$356 | -$7,003 | -$10,399 | $17,724 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $86,308 | $93,311 | $103,710 | $85,985 |
| End Cash | $85,953 | $86,308 | $93,311 | $103,710 |
| Free Cash Flow | -$4,200 | -$6,849 | -$6,470 | -$3,366 |